From July 1, 2022 to September 30, 2022, the company has repurchased 5,000 shares, representing 0.01% for Ã9.95 million. With this, the company has completed the repurchase of 199,900 shares, representing 0.45% for Ã410.24 million under the buyback announced on May 11, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,001 JPY | -5.12% | -5.57% | -0.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.79% | 566M | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- 4559 Stock
- News Zeria Pharmaceutical Co., Ltd.
- Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.